We recently published a list of Jim Cramer Discussed These 29 Stocks Ahead Of Major AI Event. In this article, we are going ...

Shares of Merck & Co. Inc. MRK sank 0.60% to $99.25 Friday, on what proved to be an all-around rough trading session for the ...

Merck & Co Inc (MRK) stock saw a decline, ending the day at $99.85 which represents a decrease of $-1.17 or -1.16% from the prior close of $101.02. The stock opened at $100.7 and touched a low of $98.

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...

IO Biotech, Inc. (IOBT), a clinical-stage biopharmaceutical company, Thursday, announced that it has completed enrollment ahead of ...

Exelixis, Inc. EXEL announced that the FDA has notified it about an update to its supplemental new drug application (sNDA) ...

A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

RingCentral (RNG) shares have gained nearly 19% over the past six months, driven by expanding AI initiatives, strong demand ...

Shares slumped in volatile trading on Wall Street following the release of a stronger-than-expected US non-farm payrolls ...